HEADER LYASE 12-FEB-14 4OYM TITLE HUMAN SOLAC COMPLEXED WITH (4-AMINO-FURAZAN-3-YL)-(3-METHOXY-PHENYL)- TITLE 2 METHANONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AH-RELATED PROTEIN, ADENYLATE CYCLASE HOMOLOG, GERM CELL COMPND 5 SOLUBLE ADENYLYL CYCLASE, SAC, TESTICULAR SOLUBLE ADENYLYL CYCLASE; COMPND 6 EC: 4.6.1.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADCY10, SAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS LYASE EXPDTA X-RAY DIFFRACTION AUTHOR M.VINKOVIC REVDAT 3 27-DEC-23 4OYM 1 SOURCE REMARK REVDAT 2 01-OCT-14 4OYM 1 JRNL REVDAT 1 02-APR-14 4OYM 0 JRNL AUTH S.M.SAALAU-BETHELL,V.BERDINI,A.CLEASBY,M.CONGREVE,J.E.COYLE, JRNL AUTH 2 V.LOCK,C.W.MURRAY,M.A.O'BRIEN,S.J.RICH,T.SAMBROOK, JRNL AUTH 3 M.VINKOVIC,J.R.YON,H.JHOTI JRNL TITL CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLATE CYCLASE REVEALS JRNL TITL 2 A DISTINCT, HIGHLY FLEXIBLE ALLOSTERIC BICARBONATE BINDING JRNL TITL 3 POCKET. JRNL REF CHEMMEDCHEM V. 9 823 2014 JRNL REFN ESSN 1860-7187 JRNL PMID 24616449 JRNL DOI 10.1002/CMDC.201300480 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 57151 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2877 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.74 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.81 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3285 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2343 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3088 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE : 0.2708 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 197 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3742 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 543 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.86170 REMARK 3 B22 (A**2) : -0.86170 REMARK 3 B33 (A**2) : 1.72340 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.199 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.104 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.106 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.099 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.103 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3887 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5263 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1349 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 95 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 576 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3881 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 496 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5158 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 6.41 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.29 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|0 - A|468 } REMARK 3 ORIGIN FOR THE GROUP (A): 21.6551 25.4244 -0.6055 REMARK 3 T TENSOR REMARK 3 T11: -0.0721 T22: -0.0290 REMARK 3 T33: -0.0409 T12: 0.0090 REMARK 3 T13: 0.0034 T23: 0.0233 REMARK 3 L TENSOR REMARK 3 L11: 0.3461 L22: 0.4294 REMARK 3 L33: 0.5448 L12: -0.0831 REMARK 3 L13: 0.2175 L23: -0.0847 REMARK 3 S TENSOR REMARK 3 S11: -0.0277 S12: -0.0385 S13: -0.0006 REMARK 3 S21: 0.0131 S22: 0.0482 S23: 0.1079 REMARK 3 S31: -0.0382 S32: -0.1530 S33: -0.0205 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OYM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1000200261. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57152 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 84.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1UL OF PROTEIN SOLUTION WAS MIXED WITH REMARK 280 1UL OF RESERVOIR SOLUTION (0.1M SODIUM ACETATE, PH 4.8, 0.2M REMARK 280 TRISODIUM CITRATE, 16-18% PEG4K AND 10% GLYCEROL) AND LEFT TO REMARK 280 EQUILIBRATE AT 4C, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.98200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.98200 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.98200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 99.34300 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 49.67150 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 86.03356 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 750 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 469 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 468 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 65 C - N - CA ANGL. DEV. = -16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 5 -158.72 -90.58 REMARK 500 GLU A 6 97.98 55.04 REMARK 500 MET A 64 -133.20 60.16 REMARK 500 THR A 132 64.49 -116.16 REMARK 500 GLU A 136 47.20 37.00 REMARK 500 GLU A 137 86.07 60.76 REMARK 500 LEU A 139 35.35 -79.52 REMARK 500 ASP A 140 0.88 -69.20 REMARK 500 ASP A 159 -155.60 -122.97 REMARK 500 ASP A 258 94.36 -165.15 REMARK 500 PHE A 338 -73.74 -134.00 REMARK 500 ASP A 339 36.66 -76.90 REMARK 500 LYS A 340 49.08 39.81 REMARK 500 GLU A 353 32.33 -143.98 REMARK 500 PRO A 356 -71.05 -55.76 REMARK 500 ASP A 357 49.94 -69.84 REMARK 500 LYS A 378 -4.89 80.99 REMARK 500 ASN A 436 22.50 -79.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 941 DISTANCE = 6.67 ANGSTROMS REMARK 525 HOH A 979 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH A 983 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A1001 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH A1040 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH A1097 DISTANCE = 6.80 ANGSTROMS REMARK 525 HOH A1103 DISTANCE = 7.10 ANGSTROMS REMARK 525 HOH A1104 DISTANCE = 6.11 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1ZC A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OYA RELATED DB: PDB REMARK 900 RELATED ID: 4OYB RELATED DB: PDB REMARK 900 RELATED ID: 4OYI RELATED DB: PDB REMARK 900 RELATED ID: 4OYO RELATED DB: PDB REMARK 900 RELATED ID: 4OYP RELATED DB: PDB REMARK 900 RELATED ID: 4OYW RELATED DB: PDB REMARK 900 RELATED ID: 4OYX RELATED DB: PDB REMARK 900 RELATED ID: 4OYZ RELATED DB: PDB REMARK 900 RELATED ID: 4OZ2 RELATED DB: PDB REMARK 900 RELATED ID: 4OZ3 RELATED DB: PDB DBREF 4OYM A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 4OYM ACE A 0 UNP Q96PN6 ACETYLATION SEQRES 1 A 470 ACE MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO SEQRES 2 A 470 ILE VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL SEQRES 3 A 470 TYR GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR SEQRES 4 A 470 PHE ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE SEQRES 5 A 470 THR ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET SEQRES 6 A 470 ASP ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR SEQRES 7 A 470 HIS ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY SEQRES 8 A 470 GLY ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA SEQRES 9 A 470 LEU TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE SEQRES 10 A 470 THR VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU SEQRES 11 A 470 PHE GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG SEQRES 12 A 470 VAL LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU SEQRES 13 A 470 VAL PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE SEQRES 14 A 470 GLY GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET SEQRES 15 A 470 ALA GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP SEQRES 16 A 470 GLN LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL SEQRES 17 A 470 PRO ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO SEQRES 18 A 470 PRO PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS SEQRES 19 A 470 THR THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS SEQRES 20 A 470 ASN LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO SEQRES 21 A 470 GLU LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER SEQRES 22 A 470 ILE LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR SEQRES 23 A 470 LEU SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN SEQRES 24 A 470 LEU MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY SEQRES 25 A 470 PRO ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL SEQRES 26 A 470 LEU LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET SEQRES 27 A 470 PHE ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE SEQRES 28 A 470 PRO GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU SEQRES 29 A 470 GLU CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL SEQRES 30 A 470 HIS LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY SEQRES 31 A 470 ILE VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS SEQRES 32 A 470 GLU TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA SEQRES 33 A 470 ARG MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SEQRES 34 A 470 SER VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE SEQRES 35 A 470 PHE LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA SEQRES 36 A 470 ASP SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU SEQRES 37 A 470 LYS VAL MODRES 4OYM CME A 253 CYS MODIFIED RESIDUE HET ACE A 0 3 HET CME A 253 10 HET 1ZC A 501 25 HET GOL A 502 6 HET GOL A 503 6 HETNAM ACE ACETYL GROUP HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM 1ZC (4-AZANYL-1,2,5-OXADIAZOL-3-YL)-(3-METHOXYPHENYL) HETNAM 2 1ZC METHANONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 ACE C2 H4 O FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 1ZC C10 H9 N3 O3 FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 HOH *543(H2 O) HELIX 1 AA1 TRP A 11 ALA A 18 1 8 HELIX 2 AA2 PRO A 21 TYR A 26 1 6 HELIX 3 AA3 ILE A 48 ALA A 53 1 6 HELIX 4 AA4 MET A 54 ASP A 65 5 12 HELIX 5 AA5 ARG A 66 PHE A 89 1 24 HELIX 6 AA6 GLU A 108 LYS A 110 5 3 HELIX 7 AA7 GLN A 111 PHE A 130 1 20 HELIX 8 AA8 GLY A 169 ALA A 182 1 14 HELIX 9 AA9 SER A 190 CYS A 197 1 8 HELIX 10 AB1 ASN A 225 THR A 234 1 10 HELIX 11 AB2 THR A 235 MET A 237 5 3 HELIX 12 AB3 SER A 242 LYS A 246 5 5 HELIX 13 AB4 ARG A 250 LEU A 255 5 6 HELIX 14 AB5 ASP A 258 LYS A 267 1 10 HELIX 15 AB6 MET A 270 ASP A 278 1 9 HELIX 16 AB7 LYS A 306 PHE A 328 1 23 HELIX 17 AB8 ASP A 357 SER A 374 1 18 HELIX 18 AB9 GLY A 408 TYR A 421 1 14 HELIX 19 AC1 ASP A 428 SER A 435 1 8 HELIX 20 AC2 PRO A 438 TYR A 440 5 3 SHEET 1 AA1 5 ASP A 92 PHE A 96 0 SHEET 2 AA1 5 ALA A 100 ARG A 106 -1 O LEU A 104 N ASP A 92 SHEET 3 AA1 5 PHE A 35 ASP A 47 -1 N MET A 44 O ALA A 103 SHEET 4 AA1 5 LYS A 144 GLY A 158 -1 O ILE A 152 N PHE A 39 SHEET 5 AA1 5 SER A 163 ILE A 168 -1 O LEU A 166 N LEU A 155 SHEET 1 AA2 7 ASP A 92 PHE A 96 0 SHEET 2 AA2 7 ALA A 100 ARG A 106 -1 O LEU A 104 N ASP A 92 SHEET 3 AA2 7 PHE A 35 ASP A 47 -1 N MET A 44 O ALA A 103 SHEET 4 AA2 7 LYS A 144 GLY A 158 -1 O ILE A 152 N PHE A 39 SHEET 5 AA2 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AA2 7 GLN A 210 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AA2 7 ILE A 202 VAL A 207 -1 N GLU A 203 O ASN A 216 SHEET 1 AA3 5 GLN A 331 MET A 337 0 SHEET 2 AA3 5 GLY A 341 PHE A 348 -1 O SER A 343 N PHE A 336 SHEET 3 AA3 5 GLU A 288 PHE A 301 -1 N VAL A 295 O CYS A 346 SHEET 4 AA3 5 ILE A 379 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA3 5 ARG A 401 ILE A 407 -1 O GLU A 403 N VAL A 396 SHEET 1 AA4 7 GLN A 331 MET A 337 0 SHEET 2 AA4 7 GLY A 341 PHE A 348 -1 O SER A 343 N PHE A 336 SHEET 3 AA4 7 GLU A 288 PHE A 301 -1 N VAL A 295 O CYS A 346 SHEET 4 AA4 7 ILE A 379 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA4 7 VAL A 425 CYS A 427 1 O THR A 426 N ILE A 384 SHEET 6 AA4 7 TYR A 460 TYR A 462 -1 O TYR A 460 N CYS A 427 SHEET 7 AA4 7 PHE A 442 GLU A 444 -1 N LYS A 443 O GLN A 461 LINK C ACE A 0 N MET A 1 1555 1555 1.33 LINK C ALA A 252 N CME A 253 1555 1555 1.36 LINK C CME A 253 N THR A 254 1555 1555 1.34 CISPEP 1 ARG A 33 PRO A 34 0 3.82 SITE 1 AC1 10 PHE A 45 LYS A 95 ALA A 97 LEU A 102 SITE 2 AC1 10 LEU A 166 VAL A 167 ARG A 176 PHE A 336 SITE 3 AC1 10 MET A 337 PHE A 338 SITE 1 AC2 7 HIS A 162 THR A 322 GLY A 330 GLN A 331 SITE 2 AC2 7 ILE A 332 HOH A 854 HOH A 954 SITE 1 AC3 9 ILE A 24 VAL A 25 GLY A 27 HIS A 28 SITE 2 AC3 9 PHE A 29 LEU A 261 SER A 264 TYR A 268 SITE 3 AC3 9 HOH A1131 CRYST1 99.343 99.343 97.964 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010066 0.005812 0.000000 0.00000 SCALE2 0.000000 0.011623 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010208 0.00000 HETATM 1 C ACE A 0 63.179 12.656 26.534 1.00 37.86 C ANISOU 1 C ACE A 0 4923 4636 4824 378 -891 -3 C HETATM 2 O ACE A 0 63.770 13.694 26.193 1.00 36.56 O ANISOU 2 O ACE A 0 4715 4490 4687 353 -903 -14 O HETATM 3 CH3 ACE A 0 63.325 12.058 27.964 1.00 39.38 C ANISOU 3 CH3 ACE A 0 5175 4810 4980 404 -942 6 C